1-3 of 3
mastocytosis
Close
Sort by
Journal Articles

A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis

Clinical Trials & Observations
Jason Gotlib, John H. Baird, Tracy I. George, Cheryl Langford, Isabel Reyes, Justin Abuel, Cecelia Perkins, Kurt Schroeder, Prithviraj Bose, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2264–2271.
https://doi.org/10.1182/bloodadvances.2019000152
Published: 2019
Includes: Supplemental data
Journal Articles

Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models

Animesh Pardanani, Sahrish Shah, Francesco Mannelli, Yoseph C. Elala, Paola Guglielmelli, Terra L. Lasho, Mrinal M. Patnaik, Naseema Gangat, Rhett P. Ketterling, Kaaren K. Reichard, Curtis A. Hanson, Alessandro M. Vannucchi, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2964–2972.
https://doi.org/10.1182/bloodadvances.2018026245
Published: 2018
Journal Articles

Variability of PD-L1 expression in mastocytosis

Clinical Trials & Observations
Ellen W. Hatch, Mary Beth Geeze, Cheyenne Martin, Mohamed E. Salama, Karin Hartmann, Gregor Eisenwort, Katharina Blatt, Peter Valent, Jason Gotlib, Ji-Hyun Lee, Lu Chen, Heather H. Ward, Diane S. Lidke, Tracy I. George
Journal: Blood Advances
Blood Adv (2018) 2 (3): 189–199.
https://doi.org/10.1182/bloodadvances.2017011551
Published: 2018
Includes: Supplemental data